ARS Pharmaceuticals, Inc. (SPRY) total debt

Total debt · fiscal 2025
$96.37M

ARS Pharmaceuticals, Inc. (SPRY) carried total debt of $96.37M at the end of fiscal 2025 (December 31, 2025). That is 229361.9% higher than the $42.00K of fiscal 2024. Figures as of 18 Nov 2026, 01:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$96.37M
Change on fiscal 2024
+229361.9%
Highest on record
$96.37Mfiscal 2025
Lowest on record
$42.00Kfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ARS Pharmaceuticals, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $96.37M in fiscal 2025 and the lowest $42.00K in fiscal 2024.

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

ARS Pharmaceuticals, Inc. total debt, year by year

ARS Pharmaceuticals, Inc. (SPRY) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$96.37M 229,361.9% up0.8×
2024$42.00K 84.7% down0.0×
2023$274.00K 43.0% down0.0×
2022$481.00K—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on SPRY

ARS Pharmaceuticals, Inc., figure by figure

ARS Pharmaceuticals, Inc. (SPRY) overview: price, valuation and scorecard

ARS Pharmaceuticals, Inc. total debt: questions and answers

How much debt does ARS Pharmaceuticals, Inc. have?

ARS Pharmaceuticals, Inc. (SPRY) carried total debt of $96.37M at the end of fiscal 2025 (December 31, 2025). That is 229361.9% higher than the $42.00K of fiscal 2024.

What are the highest and lowest total debt figures on record for ARS Pharmaceuticals, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $96.37M in fiscal 2025 and the lowest $42.00K in fiscal 2024.

How does ARS Pharmaceuticals, Inc.'s debt compare with its equity?

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

How is ARS Pharmaceuticals, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ARS Pharmaceuticals, Inc. (SPRY) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/SPRY/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.